HOPE LYON: Open Payments
NPI 1902667736 · GILLETTE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $69 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $65 |
| Astellas Pharma US Inc | 2 | $51 |
| Amgen Inc. | 3 | $48 |
| Novo Nordisk Inc | 2 | $45 |
| Reprise Biomedical, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: REZDIFFRA, Veozah, Wegovy, Miro3D, BREZTRI, OTEZLA, OPSUMIT, REPATHA.
Industry payments across WY — which companies pay providers there.
